BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Allen A, Perera S, Mettananda S, Rodrigo R, Perera L, Darshana T, Moggach F, Jackson Crawford A, Heirene L, Fisher C, Olivieri N, Rees D, Premawardhena A, Allen S. Oxidative status in the β-thalassemia syndromes in Sri Lanka; a cross-sectional survey. Free Radic Biol Med 2021;166:337-47. [PMID: 33677065 DOI: 10.1016/j.freeradbiomed.2021.02.028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Mettananda S. Genetic and Epigenetic Therapies for β-Thalassaemia by Altering the Expression of α-Globin Gene. Front Genome Ed 2021;3:752278. [PMID: 34713267 DOI: 10.3389/fgeed.2021.752278] [Reference Citation Analysis]
2 Yasara N, Wickramarathne N, Mettananda C, Silva I, Hameed N, Attanayaka K, Rodrigo R, Wickramasinghe N, Perera L, Manamperi A, Premawardhena A, Mettananda S. A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia. Sci Rep 2022;12:2752. [PMID: 35177777 DOI: 10.1038/s41598-022-06774-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]